PEG 3350 Dosing for Toddlers with Constipation
For toddlers aged 12 months to 3 years with functional constipation, start polyethylene glycol (PEG) 3350 at 0.8 g/kg/day mixed in at least 4–8 ounces of liquid, titrating every 3 days to achieve 1–2 soft, painless stools daily. 1, 2, 3
Initial Dosing Strategy
Starting dose: Begin with 0.8 g/kg/day of PEG 3350 powder mixed in a minimum of 4–8 ounces of any liquid (water, juice, milk, or formula). 1, 2, 3
Dose range: The effective maintenance dose in toddlers typically falls between 0.7–0.8 g/kg/day, though the range can extend from 0.26 to 1.42 g/kg/day based on individual response. 1, 2, 4, 3
Titration schedule: Adjust the dose every 3 days based on stool frequency and consistency to achieve the target of 1–2 soft, painless bowel movements daily. 4, 3
Practical Administration Details
Mixing requirements: Dissolve the powder completely in at least 4–8 ounces of liquid; insufficient liquid volume is the most common cause of treatment failure. 1, 5
Beverage selection: Any palatable liquid works—water, juice (especially those containing sorbitol for synergistic osmotic effect), milk, or formula are all acceptable. 1
Timing: Can be given once daily or divided into multiple doses throughout the day, whichever improves compliance. 2, 3
Expected Response Timeline
Initial response: Most toddlers experience relief within 2–4 days of starting therapy at an adequate dose with proper hydration. 5
Success rate: PEG relieves constipation in 85–97% of toddlers in short-term use (≤4 months) and 91% with long-term therapy (≥6 months). 2, 3
Stool frequency improvement: Expect an increase from baseline of approximately 2–3 stools/week to 7–17 stools/week during treatment. 6, 4
Safety Profile in Toddlers
Common adverse effects: Transient diarrhea (resolves with dose reduction), increased flatulence, and mild abdominal distension are the most frequent side effects, all dose-dependent and generally mild. 1, 2, 3
Serious adverse events: Extremely rare in this age group; no clinically significant electrolyte disturbances, metabolic abnormalities, or serious complications have been reported in pediatric studies. 1, 2, 3
Long-term safety: PEG has been used safely in toddlers for up to 21 months continuously, with an average treatment duration of 6–11 months demonstrating sustained efficacy and tolerability. 1, 2, 3
Critical Implementation Points
Before initiating PEG:
- Rule out fecal impaction by digital rectal examination; if present, perform manual disimpaction or use a glycerin suppository/enema before starting oral PEG. 1
- Exclude bowel obstruction, paralytic ileus, or anatomic abnormalities (Hirschsprung disease, anal stenosis) through history and physical examination. 1
During treatment:
- Ensure adequate daily fluid intake beyond just the mixing liquid—PEG requires water throughout the day to exert its osmotic effect. 1, 5
- Continue maintenance dosing once bowel movements normalize rather than stopping abruptly; 61.7% of patients require additional intervention within 30 days of discontinuation. 5
Managing Inadequate Response
If no bowel movement after 3–4 days of optimal PEG dosing:
- Add a glycerin suppository (pediatric size) or bisacodyl suppository (5 mg) while continuing PEG to exploit complementary mechanisms. 1
For persistent constipation despite adequate PEG dose:
- Consider adding an oral stimulant laxative (senna 2.5–5 mg daily or bisacodyl 2.5–5 mg daily) to the PEG regimen, administered approximately 30 minutes after meals to exploit the gastrocolic reflex. 1
If treatment appears to fail:
- First verify adequate liquid volume (≥4 oz per dose), confirm sufficient daily fluid intake throughout the day, and ensure proper dose calculation based on current weight. 1, 5
- Increase the PEG dose incrementally (e.g., by 0.2 g/kg/day) every 3 days until achieving 1–2 soft stools daily, up to a maximum of approximately 1.4 g/kg/day. 4, 3
Comparison to Lactulose
PEG is superior to lactulose in toddlers and should be the first-line osmotic laxative choice. 7, 6
Efficacy advantage: PEG achieves a 56% success rate versus 29% for lactulose in pediatric constipation, with significantly fewer side effects (less abdominal pain, straining, and pain at defecation). 6
Dosing comparison: Effective PEG dose is 0.26 g/kg/day versus lactulose 0.66 g/kg/day, meaning PEG requires less than half the weight-based dose. 6
Tolerability: Lactulose causes significantly more bloating and flatulence due to colonic bacterial fermentation, which limits its use; PEG's only notable disadvantage is occasional reports of bad taste. 7, 6
Common Clinical Pitfalls to Avoid
Inadequate liquid volume: Using less than 4 ounces of liquid per dose dramatically reduces efficacy—this is the single most common cause of apparent treatment failure. 1, 5
Insufficient daily hydration: Parents must understand that adequate fluid intake throughout the entire day (not just with the PEG dose) is essential for osmotic laxative action. 1, 5
Premature discontinuation: Stopping PEG as soon as stools normalize leads to rapid recurrence; continue maintenance therapy for several months, then taper gradually. 1, 5
Delaying rectal intervention: Waiting beyond 3–4 days without a bowel movement increases the risk of fecal impaction; add suppository or enema promptly. 1
Underdosing: Starting too low (e.g., 0.4 g/kg/day) and failing to titrate upward when response is inadequate; the evidence supports starting at 0.8 g/kg/day in toddlers. 2, 4, 3